ERCC1 and XRCC1 Gene Polymorphisms Predict Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer-Reference-Cited by-同舟云学术

ERCC1 and XRCC1 Gene Polymorphisms Predict Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer

Published:2009-05-07 Issue:8 Volume:13 Page:1411-1421
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Warnecke-Eberz Ute,Vallböhmer Daniel,Alakus Hakan,Kütting Fabian,Lurje Georg,Bollschweiler Elfriede,Wienand-Dorweiler Anke,Drebber Uta,Hölscher Arnulf H.,Metzger Ralf

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11605-009-0881-z.pdf

Reference52 articles.

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin 2007;57:43–66. doi: 10.3322/canjclin.57.1.43 .

2. Rouvelas I, Zeng W, Lindblad M, Viklund P, Ye W, Lagergren J. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 2005;6:864–870. doi: 10.1016/S1470-2045(05)70347-8 .

3. Sherman CA, Turrisi AT, Wallace MB, Reed CE. Locally advanced esophageal cancer. Curr Treat Options Oncol 2002;3:475–485. doi: 10.1007/s11864-002-0067-3 .

4. Leichman CG, Benedetti JK, Zalupski MM, Hochster H, Shields AF, Lenz HJ, Wade Iii IL, Bearden Iii JD, Macdonald JS. Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study. Clin Colorectal Cancer 2004;5:119–123. doi: 10.3816/CCC.2005.n.024 .

5. Kaklamanos I, Walker G, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for respectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol 2003;10:754–761. doi: 10.1245/ASO.2003.03.078 .

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective;Pharmacology & Therapeutics;2024-02

2. Change in stage after neoadjuvant chemoradiation is associated with survival in patients with esophageal cancer;Journal of Surgical Oncology;2023-06-08

3. AGR2 expression as a predictive biomarker for therapy response in esophageal squamous cell carcinoma;PLOS ONE;2022-11-03

4. Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment Outcomes;JNCI: Journal of the National Cancer Institute;2022-04-27

5. A single-nucleotide-polymorphism in the 5′-flanking region ofMSX1gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma;Therapeutic Advances in Medical Oncology;2022-01